A biotechnology company developing therapies that target the biological mechanisms of aging to treat metabolic and age-related diseases. Its platform integrates human longevity data with drug discovery to identify pathways linked to aging, with pipeline programs focused on conditions such as obesity...
Market Cap: $671.2M52W Range: $2.88 – $24.00
This page tracks all publicly disclosed congressional trades in BioAge Labs, Inc. (BIOA), a company in the Healthcare sector. 1 member of Congress has disclosed trades in this stock, including 3 purchases and 1 sale. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.